VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
WOOF
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
WOOFPetco Health and Wellness Company, Inc.
$2.96$845M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksWOOFFinancials

Petco Health and Wellness Company, Inc. (WOOF) Income Statement

8Y historyFree accessUpdated daily

Revenue growth has stalled at 0.0% in 2026Q2, while a significant gross margin expansion to 39.7% has been partially offset by a rigid cost structure, resulting in a net margin of just 2.6%.

Income StatementBalance SheetCash FlowRatios

WOOF Income Statement

Annual statement

WOOF Income Statement

Petco Health and Wellness Company, Inc. (WOOF) annual income statement — 8-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMJan'26Feb'25Feb'24Jan'23Jan'22Jan'21Feb'20Feb'19
Sales/Revenue5.97B5.96B6.12B6.26B6.04B5.81B4.92B4.43B4.39B
Revenue Growth %-1.32%-2.53%-2.22%3.63%3.94%18.03%10.95%0.96%-
Cost of Goods Sold3.65B3.66B3.79B3.9B3.61B3.38B2.81B2.53B2.49B
COGS % of Revenue-61.33%62%62.37%59.79%58.21%57.18%57.01%56.63%
Gross Profit2.32B2.31B2.32B2.35B2.43B2.43B2.11B1.91B1.9B
Gross Margin %38.81%38.67%38%37.63%40.21%41.79%42.82%42.99%43.37%
Gross Profit Growth %--0.83%-1.25%-3.02%0.02%15.18%10.5%0.09%-
Operating Expenses2.18B2.18B2.32B3.53B2.2B2.16B1.91B1.8B1.75B
OpEx % of Revenue-36.65%37.89%56.5%36.47%37.2%38.87%40.5%39.76%
Selling, General & Admin2.18B2.18B2.32B2.31B2.2B2.16B1.91B1.78B1.73B
SG&A % of Revenue-36.65%37.89%36.95%36.47%37.2%38.87%40.07%39.32%
Research & Development000000000
R&D % of Revenue---------
Other Operating Expenses0001.22B00019M373.17M
Operating Income133.49M120.43M7.05M-1.18B225.56M266.07M194.42M110.6M-214.72M
Operating Margin %2.24%2.02%0.12%-18.87%3.74%4.58%3.95%2.49%-4.89%
Operating Income Growth %-1608.03%100.6%-623.28%-15.23%36.85%75.79%151.51%-
EBITDA330.99M317.14M206.78M-979.53M419.39M438.5M369.26M284.14M-27.72M
EBITDA Margin %5.55%5.32%3.38%-15.66%6.95%7.55%7.51%6.41%-0.63%
EBITDA Growth %12.9%53.37%121.11%-333.56%-4.36%18.75%29.96%1124.94%-
D&A (Non-Cash Add-back)197.5M196.71M199.73M200.78M193.83M172.43M174.84M173.54M187M
EBIT146.25M146.53M15.56M-1.17B213.92M279.79M177.53M110.94M-214.76M
Net Interest Income-121.72M-124.89M-139.82M-147.5M-100.61M-77.33M-218.43M-252.68M-243.32M
Interest Income8.03M6.3M3.71M3.4M1.03M62K653K335K420K
Interest Expense129.75M131.2M143.53M150.91M101.64M77.4M219.08M253.02M243.74M
Other Income/Expense-121.78M-105.1M-116.35M-127.51M-100.3M-52.79M-235.98M-250.24M-243.78M
Pretax Income11.71M15.33M-109.3M-1.31B125.26M213.28M-41.55M-139.64M-458.5M
Pretax Margin %0.2%0.26%-1.79%-20.91%2.08%3.67%-0.84%-3.15%-10.44%
Income Tax-13.36M6.27M-7.48M-27.61M35.35M53.47M-3.34M-35.66M-45.84M
Effective Tax Rate %-114.06%40.87%6.84%2.11%28.22%25.07%8.03%25.54%10%
Net Income30.27M9.07M-101.82M-1.28B90.8M164.42M-26.48M-95.87M-413.79M
Net Margin %0.51%0.15%-1.66%-20.47%1.5%2.83%-0.54%-2.16%-9.42%
Net Income Growth %207.34%108.9%92.05%-1509.91%-44.77%720.84%72.38%76.83%-
Net Income (Continuing)25.07M9.07M-101.82M-1.28B89.91M159.81M-38.22M-103.98M-413.79M
Discontinued Operations000000000
Minority Interest00000-18.2M-13.58M-8.33M0
EPS (Diluted)0.100.03-0.37-4.780.340.62-0.13-0.07-0.28
EPS Growth %196.8%108.57%92.26%-1505.88%-45.16%576.92%-97.87%76.54%-
EPS (Basic)-0.03-0.37-4.780.340.62-0.13-0.07-0.28
Diluted Shares Outstanding290.5M286.15M273.41M267.55M265.95M265.34M210.68M1.46B1.46B
Basic Shares Outstanding285.63M279.56M273.41M267.55M265.52M265.19M203.72M1.44B1.46B
Dividend Payout Ratio---------

Key Metrics

Growth RegimeStable
ProfitabilityStrained
Balance SheetVulnerable
Cash FlowMixed
Top Statement Risk

Leverage constrains strategic pivot

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Top-Line Stagnation Amidst Strategic Pivot

Petco's revenue growth has decelerated from a 1.2% increase in 2024Q3 to a flat 0.0% in 2026Q2, indicating the company's transformation strategy has yet to generate meaningful top-line momentum despite recent positive comp commentary.

The sequential deceleration in revenue growth, culminating in a flat quarter, suggests the company is struggling to expand its addressable market or capture share in a competitive landscape. This stagnation is particularly concerning given the high fixed-cost base of its physical service network, as revenue growth is critical to absorbing those costs and improving operating leverage. The lack of growth implies the 'health and wellness' platform pivot is not yet translating into accelerated customer acquisition or wallet share gains.

Gross Margin Recovery Masked by Operating Inefficiency

Gross margin expanded significantly from 34.7% in 2024Q4 to 39.7% in 2026Q2, yet operating margin remains below 3.5%, indicating that cost discipline in COGS is being offset by persistent overhead and service ramp-up expenses.

The 500 basis point improvement in gross margin over the last six quarters is a positive signal, likely reflecting better product mix, private-label penetration, or reduced promotional activity. However, the failure of this gross profit expansion to flow through to the bottom line—evidenced by operating margin peaking at just 3.2%—points to a structural issue with SG&A and the fixed costs of the veterinary clinic rollout. This disconnect suggests the company's cost structure is not yet optimized for its current revenue scale.

Operating Leverage Remains Elusive

Despite a $52.2 million year-over-year increase in gross profit from 2024Q2 to 2026Q2, operating income only grew by $45.3 million, demonstrating that incremental revenue is not generating proportional operating profit due to a rigid cost base.

The data shows that for every dollar of incremental gross profit generated over the two-year period, approximately 87 cents was consumed by higher operating expenses. This indicates a near-complete lack of operating leverage, which is a critical flaw for a company attempting a capital-intensive transformation. The implication is that the business model requires a significantly higher revenue base or a fundamental restructuring of its overhead to achieve meaningful profit expansion.

SG&A Discipline is the Primary Margin Lever

SG&A as a percentage of revenue has been reduced from 39.9% in 2024Q1 to 36.2% in 2026Q2, representing the sole driver of the company's path to profitability in the absence of revenue growth.

The consistent reduction in SG&A intensity is the most encouraging trend in the income statement, suggesting management is successfully controlling corporate overhead and store-level expenses. However, this cost-cutting appears to be reaching a point of diminishing returns, as the rate of improvement has slowed in recent quarters. With R&D at zero and COGS largely market-driven, further margin expansion will be exceptionally difficult without a renewed focus on revenue growth or a more aggressive rationalization of the store footprint.

The Pivot to Profitability in 2025

The period from 2024Q4 to 2025Q2 marks a clear operational inflection, where the company moved from consistent net losses to sustained, albeit thin, profitability, driven by a sharp improvement in gross margin.

This inflection was not driven by revenue growth, which remained negative, but by a decisive improvement in gross margin from the mid-30s to the high-30s. This suggests a successful shift in product mix, pricing strategy, or inventory management that has permanently reset the company's gross profit profile. The lasting impact is a new baseline of profitability, but the challenge has now shifted from achieving profitability to generating a sufficient return on the capital invested in the business.

The Margin Illusion and Leverage Trap

The narrative of margin expansion may be masking a core vulnerability: with a debt-to-equity ratio of 2.46 and net margin of just 0.2%, the company has virtually no buffer to absorb a consumer downturn or a rise in input costs.

Short-sellers would focus on the fact that the entire profitability story rests on gross margin improvement in a zero-growth environment, which is inherently unsustainable. The razor-thin net margin means any operational misstep, competitive pricing action, or increase in interest expense could immediately push the company back into losses. Furthermore, the high leverage constrains financial flexibility, potentially forcing management to choose between deleveraging and funding the growth of its veterinary platform, creating a strategic dilemma that could destroy long-term value.

WOOF — Frequently Asked Questions

Quick answers to the most common questions about buying WOOF stock.

What was Petco Health and Wellness Company, Inc.'s (WOOF) revenue in 2025?

For fiscal year 2025, Petco Health and Wellness Company, Inc. (WOOF) reported total revenue of $5.96B. This represents a 35.7% increase compared to $4.39B in 2018.

Is Petco Health and Wellness Company, Inc. (WOOF) profitable?

Petco Health and Wellness Company, Inc. (WOOF) is profitable, generating $9.1M in net income for the fiscal year ending 2025 with a net profit margin of 0.2%.

What is Petco Health and Wellness Company, Inc.'s operating profit margin?

Petco Health and Wellness Company, Inc. (WOOF) reported an operating income of $120.4M, resulting in an operating profit margin of 2.0%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Petco Health and Wellness Company, Inc.'s gross profit and gross margin?

Petco Health and Wellness Company, Inc. (WOOF) generated $2.31B in gross profit for the year, representing a gross profit margin of 38.7%. This demonstrates the company's core pricing power and production efficiency.